Determination of cytokines in synovial fluids: correlation with diagnosis and histomorphological characteristics of synovial tissue. - Wikidata - wikimedia - TriplyDB

Determination of cytokines in synovial fluids: correlation with diagnosis and histomorphological characteristics of synovial tissue.

Determination of cytokines in synovial fluids: correlation with diagnosis and histomorphological characteristics of synovial tissue.

http://www.wikidata.org/entity/Q33564673

about

A systems biology approach to synovial joint lubrication in health, injury, and disease Beneficial effects of cerium oxide nanoparticles in development of chondrocyte-seeded hydrogel constructs and cellular response to interleukin insults Efficacy of sustained blood levels of interleukin-1 receptor antagonist in animal models of arthritis: comparison of efficacy in animal models with human clinical data.Potential therapeutic uses of interleukin 1 receptor antagonists in human diseases.Synovial fluid concentrations and relative potency of interleukin-1 alpha and beta in cartilage and meniscus degradation Dynamic loading enhances integrative meniscal repair in the presence of interleukin-1.T cells and T-cell cytokine transcripts in the synovial membrane in patients with osteoarthritis The roles of catabolic factors in the development of osteoarthritis.Interleukin-1, tumor necrosis factor-alpha, and transforming growth factor-beta 1 and integrative meniscal repair: influences on meniscal cell proliferation and migration.Interleukin-1 receptor antagonist as therapy for inflammatory disorders.Uric acid is a danger signal of increasing risk for osteoarthritis through inflammasome activation Selenomethionine inhibits IL-1β inducible nitric oxide synthase (iNOS) and cyclooxygenase 2 (COX2) expression in primary human chondrocytes.Decreased expression of the CD3zeta chain in T cells infiltrating the synovial membrane of patients with osteoarthritis.Decrease in peripheral type 1 over type 2 T cell cytokine production in patients with rheumatoid arthritis correlates with an increase in severity of disease Therapeutic potential of targeting IL-1 and IL-18 in inflammation.Role of interleukin 1 in antigen-induced exacerbations of murine arthritis.DIO2 modifies inflammatory responses in chondrocytes.Arthroscopic synovectomy in rheumatoid arthritis of wrist Interleukin-1β induces fibroblast growth factor 2 expression and subsequently promotes endothelial progenitor cell angiogenesis in chondrocytes.The effects of adipokines on cartilage and meniscus catabolism The human anti-IL-1 beta monoclonal antibody ACZ885 is effective in joint inflammation models in mice and in a proof-of-concept study in patients with rheumatoid arthritis.Toll/Interleukin-1 Receptor Domain Derived from TcpC (TIR-TcpC) Ameliorates Experimental Autoimmune Arthritis by Down-modulating Th17 Cell Response.Inhibition of matrix metalloproteinases enhances in vitro repair of the meniscus Whole-body vibration decreases the proliferativeb response of TCD4(+) cells in elderly individuals with knee osteoarthritis Systemic bone effects of biologic therapies in rheumatoid arthritis and ankylosing spondylitis.Pathogenesis of joint destruction in rheumatoid arthritis.Gene expression profiling of rheumatoid arthritis synovial cells treated with antirheumatic drugs.Modulation of STAT-3 in rheumatoid synovial T cells suppresses Th17 differentiation and increases the proportion of Treg cells.Cytokines in healthy temporomandibular joint synovial fluid.High mobility group box protein 1 in complex with lipopolysaccharide or IL-1 promotes an increased inflammatory phenotype in synovial fibroblasts.Adiponectin may contribute to synovitis and joint destruction in rheumatoid arthritis by stimulating vascular endothelial growth factor, matrix metalloproteinase-1, and matrix metalloproteinase-13 expression in fibroblast-like synoviocytes more than Production of IL-6 by T cells from the femoral head of patients with rapidly destructive coxopathy (RDC).IL-1β/HMGB1 complexes promote The PGE2 biosynthesis pathway in synovial fibroblasts.Profiling drugs for rheumatoid arthritis that inhibit synovial fibroblast activation.Novel effects mediated by bradykinin and pharmacological characterization of bradykinin B2 receptor antagonism in human synovial fibroblasts.Synergy between adiponectin and interleukin-1β on the expression of interleukin-6, interleukin-8, and cyclooxygenase-2 in fibroblast-like synoviocytes.Bradykinin and B₂ receptor antagonism in rat and human articular chondrocytes.Joint and bone disease in mucopolysaccharidoses VI and VII: identification of new therapeutic targets and biomarkers using animal models.Buprenorphine does not impact the inflammatory response in haemophilia A mice with experimentally-induced haemarthrosis.Exercise and weight loss in obese older adults with knee osteoarthritis: a preliminary study.

P2860

Q24608533-6471B42A-890E-4800-98FF-1AEAB618B4EC Q28397627-A6A71A75-980B-4CC1-874A-D5668E85B416 Q30560117-780D39A0-CFF1-408E-BB99-EF156847D7B6 Q30863549-46E45743-BBB8-40B6-845A-DF02F0DBC106 Q33679382-1B762065-22E5-4837-9612-A1FBEDE6824C Q33860663-DB3480A1-9056-424D-BCA2-7D5F6E755321 Q33997307-5294A818-B15E-43D5-8F59-938A95C7DD73 Q34009214-EE446E40-6EC0-49EB-AD49-9EAA6BB86A86 Q34075843-02E34478-D16E-44F7-A8B9-3D463B10183F Q34452084-8C316F7A-669A-4D25-A0AB-78F70D4155BB Q34550052-FB345A8B-D68D-4328-8A38-E574661F11FC Q34645421-31FC3197-495C-4843-9A1A-779BBFC9CD5C Q35541642-EC1BB225-46DC-459B-ACB0-3487809D7176 Q35546973-DB20BE22-195E-412F-B081-89D5402253C0 Q35790840-B1CDD664-CCE4-43C0-8835-E1534146B102 Q35797922-122C66AE-B62D-43E8-ABDE-F2BB770001BC Q35877978-3BEB7101-1B81-4A82-A225-A1C54351CC6E Q36510623-4747A412-297D-4B10-94B0-26FAB8F4B533 Q36701444-8D8537BC-9B88-41C9-B59E-AAAC9ADEDD9F Q36741296-BAE936C7-ABDF-42DB-8E38-43E2CDFB6641 Q36790391-DCB5B363-A93F-4088-B678-BC5E5D22FA13 Q37066063-735C2506-CE7F-4859-9EE1-3CF746594F0C Q37171756-2F9D20CA-32EF-46C3-8405-27B91EC1943A Q37370992-130888E5-4755-43AD-A426-1A30809FA514 Q37801555-0C1C9193-991A-4507-A4BE-2E90E464E898 Q37843795-D8039F8D-C946-4A96-8244-C456F4F21B79 Q38303453-6D9488ED-528A-47AA-BFF9-658EA2D533AC Q38461240-B4532434-60E1-41C1-9BD7-650ED1007FEA Q39243652-CE2FA7A3-4AEE-4002-9607-0C046916C5DA Q39831106-C987399A-C8DB-48EE-B643-C4A9345EE909 Q41201384-38471CB2-5932-4AEB-94A0-F441B7B343D2 Q41225207-997E5646-3977-4041-9871-16E41E85B2AA Q41394835-E428C714-D086-49B2-BD7D-A4AF8A621109 Q41897831-5BE4CD26-EB9D-49EE-BD30-BEC157DFBB15 Q41974084-5DAAB191-768C-448F-9926-4790B366D141 Q42251912-81FE5D72-C910-4455-ACDE-66DFD534A381 Q42257864-7735C676-1C4E-4BB1-B020-CBA371362FD7 Q45299603-A8773761-D920-444C-954E-FCD9C2F0ADDF Q45862570-58AF1589-FE13-4920-BD9B-14B56B6D6017 Q47229833-DA492DAE-3971-4C9E-BCAC-056DC4F5BCBF

P2860

Determination of cytokines in synovial fluids: correlation with diagnosis and histomorphological characteristics of synovial tissue.

http://www.wikidata.org/entity/Q33564673

description

1992 nî lūn-bûn

@nan

1992 թուականի Յունիսին հրատարակուած գիտական յօդուած

@hyw

1992 թվականի հունիսին հրատարակված գիտական հոդված

@hy

1992年の論文

@ja

1992年論文

@yue

1992年論文

@zh-hant

1992年論文

@zh-hk

1992年論文

@zh-mo

1992年論文

@zh-tw

1992年论文

@wuu

name

Determination of cytokines in ...... cteristics of synovial tissue.

@ast

Determination of cytokines in ...... cteristics of synovial tissue.

@en

Determination of cytokines in ...... cteristics of synovial tissue.

@nl

type

label

Determination of cytokines in ...... cteristics of synovial tissue.

@ast

Determination of cytokines in ...... cteristics of synovial tissue.

@en

Determination of cytokines in ...... cteristics of synovial tissue.

@nl

prefLabel

Determination of cytokines in ...... cteristics of synovial tissue.

@ast

Determination of cytokines in ...... cteristics of synovial tissue.

@en

Determination of cytokines in ...... cteristics of synovial tissue.

@nl

P1433

Q33564673-A612290E-7198-40D0-987F-6F5D3B3B8323

P1476

Q33564673-55EC1E88-1D1D-48F7-95B6-B123DF717878

P2093

Q33564673-2B45885B-6B9B-4FBE-9240-5CA2F3E14826

Q33564673-4934E3FC-74C9-4559-A331-A14E0C4C9DF6

Q33564673-6C13B5F0-2771-4EB8-894A-9CCE3955724F

Q33564673-702FA79F-0CE0-42C5-91BF-47417D2CA414

Q33564673-AB3EE3E9-66C7-4511-971F-0D87B93DCF64

Q33564673-EFE2BC2A-4338-455E-A9C8-2545441A8AE2

P2860

Q33564673-0A98340A-BAFF-4625-B757-40B4CE2197AA

Q33564673-1BC996EB-6ED0-4EE0-AF68-25E4890EE283

Q33564673-248B43B4-3F9A-44AC-9965-BCE5E51BF793

Q33564673-407B2AFB-2685-470C-809F-B65429D506EB

Q33564673-44CA5072-B938-4529-B70B-42DBB85CB9B5

Q33564673-631D3DDE-8263-4AFD-83A4-AD78FCB31CA1

Q33564673-88EA5506-7F64-4864-879A-E9A8DC38F1D8

Q33564673-C5B75408-FF95-4243-923A-9732FAF8DA13

Q33564673-E47A1854-2E75-44CF-B749-72FFCD7A2ACE

Q33564673-E8C51CC3-7E2C-44E8-91B8-EDB8B93B89D3

P304

Q33564673-C66ADBF7-0F1C-4CFA-B437-0F879EA6BAAC

P31

Q33564673-CB8634AF-A910-4F78-863A-F202D5D44394

P356

Q33564673-BEA4C362-2087-4A2F-9E01-BEE94E890275

P407

Q33564673-CBAD0890-3502-47E3-9182-746CA90EFF64

P433

Q33564673-A9266BAE-D7A4-4CE3-8A89-083EF563D070

P478

Q33564673-73672D76-66B0-4430-9506-FC5D81AC7B77

P577

Q33564673-7BB47877-C517-4F3D-8152-44A7B641313F

P5875

Q33564673-0188565B-9935-482E-AFC8-269E0C7E1A1D

P698

Q33564673-6A8CF8CB-D343-4CC8-AF36-D0C63D85B3D2

P921

Q33564673-1f25e10b-053f-4d03-940a-a07a50752503

P932

Q33564673-2FD623B4-838D-4D69-9CA4-7316C9F83794

P356

P1433

Annals of the Rheumatic Diseases

P1476

Determination of cytokines in ...... cteristics of synovial tissue.

@en

P2093

Fritz P

http://www.w3.org/2001/XMLSchema#string

Kahle P

http://www.w3.org/2001/XMLSchema#string

Pawelec G

http://www.w3.org/2001/XMLSchema#string

Saal JG

http://www.w3.org/2001/XMLSchema#string

Schaudt K

http://www.w3.org/2001/XMLSchema#string

Zacher J

http://www.w3.org/2001/XMLSchema#string

P2860

Tumour necrosis factor in serum and synovial fluid of patients with active and severe rheumatoid arthritis.

Synovial fluid concentration of five different cytokines in rheumatic diseases

Cytokines in chronic inflammatory arthritis. I. Failure to detect T cell lymphokines (interleukin 2 and interleukin 3) and presence of macrophage colony-stimulating factor (CSF-1) and a novel mast cell growth factor in rheumatoid synovitis

Cytokines and cytokine inhibitors or antagonists in rheumatoid arthritis.

The immunohistology of synovial lining cells in normal and inflamed synovium.

Detection of interleukin 8 biological activity in synovial fluids from patients with rheumatoid arthritis and production of interleukin 8 mRNA by isolated synovial cells.

Production of tumour necrosis factor-alpha, interferon-gamma and interleukin-2 by peripheral blood mononuclear cells of subjects suffering from rheumatoid arthritis.

Lymphokine production in rheumatoid arthritis and systemic lupus erythematosus.

Cytokines in synovial fluid: II. The presence of tumour necrosis factor and interferon.

The stimulation of IL-2 production by anti-rheumatic drugs.

P304

731-734

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1136/ARD.51.6.731

http://www.w3.org/2001/XMLSchema#string

P407

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

51

http://www.w3.org/2001/XMLSchema#string

P577

1992-06-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

21540088

http://www.w3.org/2001/XMLSchema#string

P698

1616355

http://www.w3.org/2001/XMLSchema#string

P921

P932

1004735

http://www.w3.org/2001/XMLSchema#string